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ABSTRACT 
 
The incidence of infections caused by antimicrobial-resistant Enterobacteriaceae in Thailand 
is increasing and human intestinal flora is an important reservoir for these organisms. This 
study was carried out to determine the intestinal carriage of bla CTX-M extended spectrum ß-
lactamase-positive Enterobacteriaceae (ESBL + E) and AmpC-positive Enterobacteriaceae in 
a community setting in Northern Thailand, and to identify potential risk factors for carriage. 
A total of 307 fecal samples were collected from healthy volunteers in Phitsanulok province, 
and cefotaxime-resistant Enterobacteriaceae (CtxRE) were isolated using selective media. 
Polymerase chain reaction (PCR) was used to detect ESBL and AmpC genes. Risk factors 
were analyzed using multiple logistic regression. Genotyping was performed by multilocus 
sequence typing (MLST) analysis. Two hundred ninety-one CtxRE isolates were obtained 
and Escherichia coli was the predominant organism (66.3%). The intestinal carriage rates of 
blaCTX-M ESBL + E and AmpC-positive Enterobacteriaceae were 52.1% and 6.2%, 
respectively. Comparative levels of bla CTX-M group 1 and bla CTX-M group 9 were found 
while bla CMY-2 was the predominant genotype among AmpC genes. Co-existence of two ß-
lactamase genes in a single isolate was found in 6.5% of isolates. Consumption of under-
cooked meat was strongly associated with intestinal carriage of bla CTX-M ESBL + E 
(p = 0.003, OR = 2.133, 95% CI = 1.289–3.530). Phylogenetic grouping and MLST analysis 
of E. coli isolates revealed the presence of E. coli B2-ST131 (n = 8). Of these, seven carried 
bla CTX-M-group 9 and 1 carried blaCMY-2. Our results suggest that residents in Thailand 
are at high risk for developing endogenous infections caused by antibiotic-resistant 
Enterobacteriaceae. 
 
 
INTRODUCTION 
 
The incidence of multidrug-resistant Enterobacteriaceae (MDRE) is increasing rapidly and 
has now become a global threat [1]. Treatment of diseases caused by MDRE is far more 
challenging where treatment options are becoming limited. In particular, resistance to 
expanded-spectrum cephalosporins, monobactam and carbapenems among 
Enterobacteriaceae is increasingly reported and is usually mediated by the production of 
extended-spectrum ß-lactamase (ESBL), AmpC and carbapenemase [1]. 
 
Due to the fact that most ESBL-, AmpC- and carbapenemase-encoding genes reside on 
mobile genetic elements (MGEs), i.e. plasmids and transposons, they are readily transferrable 
among Enterobacteriaceae. Furthermore, MGEs invariably carry genes encoding for 
resistance to other classes of antibiotics, such as aminoglycosides and fluoroquinolones, 
hence facilitating the emergence and spread of MDRE [1]. MDRE are now widespread in 
hospital settings, communities and the environment [2]. The human intestine is increasingly 
recognized as an important reservoir for MDRE and thus the human-to-human transmission 
and dissemination of MDRE in communities can occur where living conditions have poor 
sanitation [3]. Furthermore, the acquisition of MDRE in healthy individuals traveling to 
endemic regions have been documented, further enhancing the international spread of MDR 
organisms [3]. 
 
Previous studies have shown that intestinal carriage by ESBL-positive Enterobacteriaceae 
(ESBL + E) has been associated with developing infection due to ESBL producers [4, 5]. 
Many studies have reported the fecal carriage of ESBL + E among healthy populations 
[6, 7, 8, 9]
. Moreover, the high carriage rates of ESBL + E (53.9–75.5%) have been reported 
among healthy residents in central Thailand [10, 11, 12, 13]. However, these rates were slightly 
lower (32%) in Northern and Southern parts of Thailand [11]. 
 
Since the incidence of infections due to ESBL + E and AmpC-positive Enterobacteriaceae 
in Thailand has continuously increased [14], this study was carried out to gain a better 
understanding of the intestinal carriage of ESBL + E and identify risk factors for ESBL + E 
carriage in a community setting in Northern Thailand. Furthermore, this study was 
extended to include the carriage rate of AmpC-positive Enterobacteriaceae. In addition, 
characterization of resistant genes and molecular analysis of resistant isolates were 
investigated. 
 
 
MATERIAL AND METHODS 
 
Study setting and ethical approval 
This prospective cohort study was conducted on healthy volunteers in Wang Thong District 
which is located in the rural area of Phitsanulok province, Northern Thailand. All subjects 
were at least 15 years of age. Participants who had diarrheal diseases within the previous 
1 month were excluded from the study. Participant recruitment and sample collection were 
assisted by local public health personnel. This study was approved by the Naresuan 
University Institutional Review Board (COA no. 49/2013). Written informed consent was 
obtained from each subject participating in the study. For the subjects who were under 
18 years old, consent was provided by their parent or guardian. 
 
Sample collection and questionnaires 
Fresh fecal sampling was performed between October and December 2013. A total of 307 
healthy volunteers participated in this study. Fecal samples were collected by subjects using 
sterile stool containers with a sterile plastic spoon. One sample was obtained from each 
participant. Microbiological analysis was carried out within 24 h. 
 
Volunteers were asked to fill in a comprehensive questionnaire to collect information 
regarding demographic data (age, gender, education, occupation, etc.), consumption of 
undercooked meat and fresh vegetables, type of drinking water, previous antibiotic use, and 
history of hospitalization. 
 
Isolation and identification of cefotaxime-resistant Enterobacteriaceae 
The fecal samples were directly cultured on Chrome UTI agar (Oxoid Ltd., Basingstoke, 
Hamshire, UK) supplemented with 25 mg/L vancomycin and 1 mg/L cefotaxime (Sigma 
Aldrich, St. Louis, MO, USA) and incubated under aerobic condition for 24 h at 37 °C. 
Colonies of different morphology were selected and subcultured onto EMB agar for further 
studies. Species identification was performed by using RapID™ ONE System (REMEL Inc., 
Lenexa, KS, USA) according to the manufacturer’s instruction. Isolates showing ambiguous 
results were further identified by sequencing of the 16S rRNA gene. 
 
Antimicrobial susceptibility testing and ESBL production 
All isolates were subjected to susceptibility testing against 12 antimicrobial agents 
(amoxicillin/clavulanic acid, cefoxitin, ceftazidime, cefepime, aztreonam, imipenem, 
meropenem, gentamicin, amikacin, ciprofloxacin, doxycycline and trimethoprim-
sulfamethoxazole) by disk diffusion method according to Clinical Laboratory Standards 
Institute (CLSI) protocols and the results were interpreted according to CLSI criteria [15]. An 
isolate was defined as MDR if it was resistant to at least three or more antimicrobial classes 
[16]
. 
 
Screening for ESBL production was performed by combination disk method according to 
CLSI guidelines using cefotaxime and ceftazidime alone or in combination with clavulanic 
acid [15]. 
 
Determination of genes encoding for CTX-M, AmpC and carbapenemase by PCR and 
sequencing 
The presence of genes encoding for CTX-M, AmpC and carbapenemase was performed by 
multiplex PCR using previously published primers and conditions [17, 18, 19]. An individual 
colony was suspended in 1 mL of water and used as template in PCR. Amplification was 
performed in a total volume of 20 μL containing 1 μL of template DNA, 1X PCR buffer, 
1.5 mM MgCl2, 0.2 mM dNTPs and 0.5 μM of each primer and 1 U of Taq polymerase 
(Vivantis Technologies, Selangor, Malaysia). DNA amplification was performed in a 
Veriti®Thermal Cycler (Applied Biosystems, CA, USA). PCR products were analyzed by 
agarose gel electrophoresis. 
 
Selected PCR products were purified using a DNA purification kit (GF-1 Nucleic Acid 
Extraction Kit; Vivantis Inc., Chino, CA, USA) and were sent to a commercial facility for 
sequencing (First BASE Laboratories Sdn Bhd, Selangor, Malaysia). Sequences were 
compared with those available in the GenBank database using the BLAST algorithm 
available on the National Center for Biotechnology Information (NCBI) website. 
 
Phylogenetic grouping and multilocus sequence typing (MLST) analysis 
Phylogenetic grouping (A, B1, B2 and D) of Escherichia coli was performed by a multiplex 
PCR assay for chuA, yjaA and DNA fragment TspE4C2 as previously described [20]. MLST 
was performed by amplification and sequencing of seven housekeeping genes (adk, fumC, 
gyrB, icd, mdh, purA and recA) according to the protocols from the E. coli MLST website  
 
Repetitive palindromic polymerase chain reaction (rep-PCR) 
Selected E. coli isolates were typed by rep-PCR as described previously [21]. The PCR 
reaction mixture consisted of 1 μL template DNA, 1X PCR buffer, 0.2 mM dNTPs, 0.5 μM 
of each primer and 1 U of Taq polymerase, in a total volume of 25 μL. DNA banding patterns 
were assessed by visual inspection. 
 
Statistical analysis 
Data were collected and analyzed using SPSS version 17.0 (SPSS, Chicago, IL, USA). 
Univariate analysis was performed using chi-square for categorical variables. Factors that 
were statistically significant in univariate analysis were included in multivariate logistic 
regression analysis to determine risk factors associated with intestinal carriage of bla CTX-
M ESBL + E. The results were presented as odds ratios (OR) with 95% confidence intervals. 
A p value <0.05 was considered a significant difference. 
 
 
RESULTS 
 
Characteristics of participants 
A total of 307 healthy volunteers were enrolled in this study. Volunteer demographics are 
shown in Table 1. The median age of participants was 51 years (range, 15–88). The 
majority of them were female, farmers and educated from primary school. 
 
Isolation of cefotaxime-resistant Enterobacteriaceae from volunteers, antimicrobial 
susceptibility testing and ESBL production 
From 307 fecal samples, cefotaxime-resistant Enterobacteriaceae (CtxRE) isolates were 
detected in 227 samples. One hundred sixty-three subjects carried one species while 64 
subjects carried two species of CtxRE resulting in a total of 291 CtxRE isolates. Species 
identification showed that the majority of isolates were Escherichia coli (66.3%, 193/291) 
followed by Enterobacter cloacae (14.8%, 43/291) and Klebsiella pneumoniae (10.3%, 
30/291). We also recovered Citrobacter spp. (3.4%), Enterobacter spp. (2.1%), Klebsiella 
spp. (1.4%), Pantoeaspp. (0.7%), Kluyvera spp. (0.7%) and Shigella spp. (0.3%). 
 
The 291 CtxRE isolates showed additional resistance to cefepime (61.9%), aztreonam 
(51.2%), trimethoprim/sulfamethoxazole (48.5%), ceftazidime (43.3%) and gentamicin 
(42.6%) (Fig. 1). A total of 10.7% of isolates were resistant to imipenem. In addition, 138 
isolates (47.4%, 138/291) were considered as MDR [16]. Phenotypic analysis showed that 
58.6% (180/307, 95% CI = 52.9%–64.2%) of volunteers carried ESBL + E in their 
intestinal tract. 
 
Detection of genes encoding for CTX-M, AmpC and carbapenemase 
Of the 291 CtxRE, 169 isolates from 160 persons were bla CTX-M ESBL + E by phenotypic 
(combination disk method) and genotypic characterization (PCR and sequencing). Hence 
the prevalence of bla CTX-M ESBL + E in healthy volunteers was 52.1% (160/307, 95% 
CI = 46.7–58.1%). 
 
Genotyping of the bla CTX-M-positive isolates revealed that bla CTX-M group 1 and bla CTX-M 
group 9were found in 51.5% (87/169) and 57.4% (97/169) of isolates, respectively. Among 
these, 10.1% (17/169) of isolates carried both bla CTX-M group 1 and bla CTX-M group 9. In 
addition, two Klebsiella spp. isolates carried bla CTX-M group 8 (Table 2). 
 
The presence of AmpC- and carbapenemase-encoding genes was investigated. Twenty-one 
isolates (mostly E. coli) from 19 subjects carried AmpC genes: 17, 3 and 1 carried bla CMY-
2, blaDHA-1 and bla MIR, respectively (Table 2). Therefore, the prevalence of AmpC-positive 
Enterobacteriaceae in healthy volunteers was 6.2% (19/307). The genes encoding for AmpC 
were found either alone or in combination with bla CTX-M. No carbapenemase genes 
(bla IMP, bla VIM, bla NDM, bla KPC and bla OXA-48) were detected. 
 
Risk factors for intestinal carriage of bla CTX-M ESBL + E 
Using univariate analysis, no significant differences in terms of age, gender, education, 
occupation, drinking tap water, consumption of fresh vegetables and history of 
hospitalization were associated with the carriage of bla CTX-M ESBL + E (Table 1). In 
contrast, consumption of undercooked meat and previous antibiotic use were significantly 
associated with bla CTX-MESBL + E carriage (p < 0.05). Accordingly, these two variables 
were included in multivariate logistic regression analysis. The result showed that 
consumption of undercooked meat was the only independent risk factor associated 
with bla CTX-M ESBL + E colonization (p = 0.003, OR = 2.133, 95% CI = 1.289–3.530) 
(Table 3). 
 
Phylogenetic grouping, MLST analysis and rep-PCR 
Phylogenetic grouping was investigated for all 193 E. coli isolates. The results showed that 
the predominant groups were A (106 isolates, 54.9%), followed by groups B1 and D (each 
group comprised 39 isolates, 20.2%) and B2 (9 isolates, 4.7%). Nine B2 isolates were 
identified as ST131 (n = 8) and ST95 (n = 1). The carriage rate of E. coli B2-ST131 among 
healthy volunteers was 2.6% (8/307). We also observed that five isolates of E. coli ST131 
showed identical rep-PCR pattern. 
 
 
DISCUSSION 
 
In this study, the intestinal carriage of antibiotic-resistant Enterobacteriacea in a community 
setting in Phitsanulok province, Northern Thailand was investigated. Our results showed a 
large number of CtxRE isolates in asymptomatic carriers. Several species were identified; 
however, the most common species was E. coli followed by E. cloacae and K. pneumoniae. 
In addition, some of these isolates showed resistance to other classes of broad-spectrum 
antibiotics, including cefepime, ceftazidime, aztreonam, gentamicin, and trimethoprim/ 
sulfamethoxazole. Furthermore, nearly half (47.4%) of isolates were classified as MDR [16]. 
 
Several reports on the intestinal carriage of ESBL + E in community settings have been 
documented. Studies in the European countries such as the Netherlands and Norway 
revealed a small number (<10%) of ESBL + E in healthy subjects [7, 9]. The relatively low 
carriage rates of ESBL + E among healthy populations were reported from Asia, including 
Japan [22] and Korea [23]. Our results showed the high prevalence of intestinal carriage 
of bla CTX-M ESBL + E (52.1%) in the community. These results were consistent with those 
reported from China [8], Southeast Asian countries, e.g. Laos and Vietnam [6], as well as 
central Thailand [10, 11, 12], although there are some differences in methodologies or number 
of subjects who participated in each study. Our results confirmed previous observations that 
Thailand is a highly endemic area for bla CTX-M ESBL + E carriage within the community 
[3]
. Previous reports from Thailand showed that bla CTX-M group 9 was the predominant ESBL-
gene found in ESBL + E among healthy volunteers [10, 11, 12]. In this study we found the 
comparative level of bla CTX-M group 1(51.5%) and bla CTX-M group 9 (57.4%) in ESBL + E, 
suggesting a shift in the prevalance of blaCTX-M genotypes. The bla CTX-M group 8, which is 
uncommon in Thailand, was also found at a low frequency. 
 
Several factors have been shown to be associated with intestinal carriage of bla CTX-
M ESBL + E in healthy volunteers, including education status, previous antibiotic usage, 
history of hospitalization and foreign travel [3, 8, 12]. In our study, consumption of under-
cooked meat was strongly identified as a risk factor associated with bla CTX-M ESBL + E 
colonization (p = 0.003) suggesting that carriage of bla CTX-M ESBL + E is driven from 
meat or farming sectors. A possible explanation could be due to fact that bla CTX-M ESBL 
+ E is frequently found in food-producing animals and their role as major reservoirs for 
ESBL + E has been well documented [24]. In addition, several studies have shown the 
presence of ESBL + E, including those containing bla CTX-M, in several types of meat and 
food-producing animals in Thailand [13, 24, 25]. Therefore the possibility exists that transfer of 
ESBL + E to human intestinal flora could occur by consumption of undercooked meat. 
In contrast to ESBL, data on the prevalence of AmpC-positive Enterobacteriaceae, to date, 
in community settings are limited although their presence in clinical isolates, environments 
and animals have been reported [26]. Our study is the first investigating AmpC-positive 
Enterobacteriaceae carriage in Thailand, the prevalence of which was 6.2%. This value is 
higher than that previously reported from European countries such as Spain and the 
Netherlands (<1%) [7, 27]. Our molecular studies of AmpC-encoding genes showed that 
bla CMY-2 is predominant, consistent with the study conducted in a Thai hospital [28]. Risk 
factors associated with the carriage of AmpC-positive Enterobacteriaceae could not be 
identified, probably due to the small number of carriage rate. However, our results 
suggested that the AmpC-producers have spread beyond hospital settings in Thailand, as 
seen in other studies elsewhere [7, 9]. In addition, the co-existence of two ß-lactamase genes 
in a single isolate were found in 6.5% of isolates (19/291) (Table 2). This may enhance the 
level of resistance or render an organism resistant to more ß-lactams. Furthermore, bla CTX-
M and bla AmpC were not detected in some CtxRE isolates. Resistance in these isolates may 
be due to the presence of other enzymes such as inhibitor-resistant ß-lactamases or porin 
alteration [1]. 
 
No carbapenemase-encoding genes were found in our study despite the fact that 10.7% of 
isolates showed resistance to imipenem (Figure 1). These results were similar to previous 
findings in the Netherlands and Switzerland [7, 29]. Although the mechanisms of carbapenem 
resistance remain unclear, the findings of carbapenem-resistant isolates among healthy 
volunteers are of concern since carbapenems are antibiotic of choice for treatment of 
infections caused by ESBL + E. Further experiments are underway to investigate the 
mechanism of carbapenem resistance in these isolates. 
 
Our study showed that eight isolates of E. coli belonged to the highly pathogenic group B2-
ST131. Of the eight E. coli ST131 isolates, seven were ESBL-producers, carried bla CTX-M-
group 9and showed ciprofloxacin resistance. The other isolate was a non-ESBL-producer, 
possessed bla CMY-2 and was ciprofloxacin susceptible. Recently, E. coli ST131 has been 
found in different origins (animals, environments and humans) and has been reported to 
cause community and hospital infections in several countries including Thailand [30, 31]. 
Transmission of E. coliST131 among members living in the same household has been 
reported [32]; nevertheless, little is known about the intestinal carriage of E. coli ST131 
among healthy subjects. Previous studies in Australia, China and France revealed that 4–
7% of healthy subjects carried E. coli ST131 in their digestive tracts [33, 34]. In this study, we 
found the low carriage rate (2.6%) of E. coliST131 among healthy volunteers. Moreover, 
we observed that five bla CTX-M-group 9-positive ST131 isolates, which were recovered from 
different participants from different families, showed identical rep-PCR pattern suggesting 
successful clonal spread of ST131 within the community. 
 
In conclusion, our data indicate a high rate of intestinal carriage of bla CTX-M ESBL + E in a 
Thai community, and that carriage is strongly associated with the consumption of under-
cooked meat. The key concern from these findings is the E. coli B2-ST131 carrying 
either bla CTX-M or bla CMY-2. Our results suggest that residents in Thailand are at high risk 
for developing infections caused by antibiotic-resistant Enterobacteriaceae. The data from 
this study have profound ramifications for public health and biosecurity containment in the 
Thai environment. Accordingly, practices such as sanitation, domestic hygiene, and 
infection control policies need to be enforced to prevent the spread of antibiotic-resistant 
human pathogens within communities. 
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Table 1 
Demographic indices related to the intestinal colonization by bla CTX-M ESBL-positive Enterobacteriaceae among healthy volunteers 
 
Variables Number of 
cases, n (%) 
Total N = 307 
Bla CTX-M ESBL + E 
carrier Number of 
cases, n (%) N = 161 
non bla CTX-M 
ESBL + E carrier 
Number of 
cases, n (%) N = 146 
Univariate analysis 
pvalue Odds ratio (95% 
CI) 
Age (>50 years) 151 (49.2) 82 (50.9) 69 (47.3) 0.394 1.224 (0.769–
1.947) 
Female gender 188 (61.2) 102 (63.4) 86 (58.9) 0.426 0.829 (0.522–
1.316) 
Primary school education 195 (63.5) 105 (65.2) 90 (61.6) 0.313 0.783 (0.491–
1.257) 
Farmers 186 (60.6) 102 (63.4) 84 (57.5) 0.299 0.768 (0.466–
1.264) 
Drinking tap waterb 142 (46.3) 72 (44.7) 70 (47.9) 0.524 0.863 (0.549–
1.357) 
Consumption of 
undercooked meatc 
141 (45.9) 87 (54.0) 54 (37.0) 0.004a 1.961 (1.231–
3.124) 
Consumption of fresh 
vegetablesd 
288 (93.8) 154 (95.7) 134 (91.8) 0.549 1.724 (0.284–
10.472) 
History of hospitalization 
within previous 6 months 
31 (10.1) 14 (8.7) 17 (11.6) 0.354 0.702 (0.332–
1.486) 
Antibiotic usage within 
previous 3 months 
100 (32.6) 62 (38.5) 38 (26.0) 0.046a 1.672 (1.007–
2.775) 
 
aStatistically significant (p < 0.05) 
bVolunteers who drink tap water daily 
cVolunteers who occasionally or regularly consume undercooked meat 
dVolunteers who occasionally or regularly consume fresh vegetables 
Table 2 
Distribution of β-lactamase genes in cefotaxime-resistant Enterobacteriaceae among healthy volunteers 
 
 
ß-lactamase genes Enterobacteriaceae (n) 
bla CTX-M group 1 (n = 70) E. coli (61), E. cloacae (5), K. pneumoniae (4) 
bla CTX-M group 8 (n = 2) K. pneumoniae (1), Klebsiella spp. (1) 
bla CTX-M group 9 (n = 78) E. coli (73), K. pneumoniae (4), Klebsiella spp.(1) 
bla CMY-2 (n = 15) E. coli (14), K. pneumoniae (1) 
bla DHA-1 (n = 3) E. coli (1), Klebsiella spp. (1), Citrobacter spp. (1) 
bla MIR (n = 1) E. cloacae (1) 
bla CTX-M group 1 + bla CTX-M group 9 (n = 17) E. coli (17) 
bla CTX-M group 9 + bla CMY-2 (n = 2) E. coli (2) 
 
 
 
  
Table 3 
Multivariate logistic regression analysis of risk factors associated with intestinal colonization of bla CTX-M ESBL-positive Enterobacteriaceae 
among healthy volunteers 
 
 
Variables p valuea Odds ratio 95% CI 
Antibiotic use within previous three months 0.089 1.573 0.934–2.651 
Consumption of undercooked meatb 0.003 2.133 1.289–3.530 
 
 
aStatistically significant (p < 0.05) 
bVolunteers who occasionally or regularly consume undercooked meat 
 
Figure 1 
 
 
 
 
 
 
Resistance rates of cefotaxime-resistant Enterobacteriaceae isolated from 
healthy volunteers (n = 291). AMC amoxicillin/clavulanate, FOX cefoxitin, 
CAZ ceftazidime, FEPcefepime, ATM aztreonam, IPM imipenem, MEM mer
openem, CN gentamicin, AKamikacin, CIP ciprofloxacin, DO doxycycline, S
XT trimethoprim/sulfamethoxazole 
 
